Info deal : Fondis Bioritech
Aca Nexia realized the Financial Due Diligence of Fondis Bioritech, specialist in diagnostic devices, on the occasion of the acquisition of the entry of InnovaFonds as a majority shareholder.
Fondis Bioritech is a SME based in the Yvelines region and specializes in real estate diagnostic instruments: it provides diagnostic tools to chemical laboratories, industrial players and to the construction industry.
In 2009, it strengthened its position in the market by acquiring Bioritech, a specialist in the analysis of liquids.
In 2017, Fondis Bioritech achieved a turnover of € 13 million. The company left the fold of Eurazeo PME for InnovaFonds, which takes the majority of the capital. For a valuation between 5 and 7 times EBITDA, InnovaFonds, has taken over alongside management (Eric Vanbalinghem) and two financial investors.
This arrival of InnovaFonds, will allow the SME to strengthen its positions on security (Customs, DGA, …) and accelerate the development of its range in equipment related to the measurement of asbestos.
Cyril Chaumien, Managing Partner at InnovaFonds: “Fondis Bioritech has demonstrated its know-how and has significant technological advances. The group will accelerate its development in asbestos and safety. This should enable the company to take a new step to become a leading player in portable scientific instrumentation with more than € 20 million in sales over the next three to four years.”